Journal
Journal of Cystic Fibrosis
Publication Date
11-1-2021
Volume
20
Issue
6
First Page
1018
Last Page
1025
Document Type
Open Access Publication
DOI
10.1016/j.jcf.2021.07.015
Rights and Permissions
Derichs N, Taylor-Cousar JL, Davies JC, Fajac I, Tullis E, Nazareth D, Downey DG, Rosenbluth D, Malfroot A, Saunders C, Jensen R, Solomon GM, Vermeulen F, Kaiser A, Willmann S, Saleh S, Droebner K, Sandner P, Bear CE, Hoffmann A, Ratjen F, Rowe SM; Rio-CF Study Group. Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis. J Cyst Fibros. 2021 Nov;20(6):1018-1025. doi: 10.1016/j.jcf.2021.07.015. © 2021 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Recommended Citation
Derichs, Nico; Rosenbluth, Daniel; and et al., "Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis." Journal of Cystic Fibrosis. 20, 6. 1018 - 1025. (2021).
https://digitalcommons.wustl.edu/oa_4/3195
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
